The new website represents InSysBio’s diverse expertise and corporate philosophy

NEWS
Press-Release
November 30, 2021

 

November 30, 2021

[Moscow – 30.11.2021] InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces the launch of its new website, https://insysbio.com/. The aim of redesign was to fully represent all InSysBio’s diversified experience and to reflect the company’s current trend. The new website is more structured, user-friendly and provides more opportunities for feedback.

Thus, InSysBio’s new website embraces Blog as one of fundamental new features. It should be outlined that its core idea is to provide a unique collection of methodological materials on QSP modeling that has no analogue. Moreover, the company’s website has undergone rebranding to declare the corporate philosophy. Now it presents InSysBio’s brand identity and main principles through the statement of its mission, vision, and values.

To start with, InSysBio can be well-deservedly called the pioneer of QSP modeling since it goes back to 2004 with the year of its foundation. InSysBio has been constantly tracking the purpose of сutting costs and risks of time-demanding process of drug development. InSysBio’s full concept of functioning aims at three main interdependent components: our partners, drug development process and patients. This chain has become the platform for the mission statement – “At InSysBio our mission is to provide QSP-modeling to world pharma to assist in efficient drug development thus bringing hope to patients”.

InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners (there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry). But still we see the potential to grow beyond this horizon and the vision statement emerges from this idea – “Our vision is to establish QSP-modeling as an essential part of pharmaceutical industry in order to dramatically reduce risks and time consumption of drug development cycle”.

Besides these directions, we undertake efforts to contribute to our corporate and global researching environment. All our commitment towards our key-audiences and corporate philosophy are covered by our values. In total, the entire concept can be briefly expressed by our slogan "Building models – Bringing hope".

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

March 2022
MoTuWeThFrSaSu
 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
1. 17 Mar 2022 14:17 InSysBio to present posters at AACR Annual Meeting 2022 InSysBio team is going to present its posters in frames of American Association for Cancer Research (AACR) Annual Meeting 2022 which is to be held April 8-13, New Orleans, Louisiana. The abstracts have been published on AACR website and E-Posters are going to be presented if frames of Poster Sessions
18
19
20
21
22
23
24
25
26
27
28
29
1. 29 Mar 2022 13:44 InSysBio to take part in QSPC2022 InSysBio announces its participation in Quantitative Systems Pharmacology Conference 2022 (QSPC2022) which is to be held on April 20-22, 2022, Leiden, The Netherlands. InSysBio team is going to present its QSP tools at the Booth and 15 posters in frames of the Conference
30
31
   
Upcoming Events
Tags
Latest News
11.07
InSysBio team to publish the new article in Journal of Pharmacokinetics and Pharmacodynamics
24.05
InSysBio to establish a new legal entity in Cyprus
25.04
InSysBio's ASCPT 2022 Micro-Theater Session on YouTube
20.01
InSysBio to release Immune Response Template v. 3.6.0
23.12
InSysBio to update CYTOCON DB and CYTOCON DB Open